Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

44 study records (showing up to 30 per record type)

• Registered trial NCT01754792 Completed (results not assessed here)
  Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose Subjects
  Condition or outcome area: Type 2 Diabetes|Impaired Glucose Tolerance|Healthy
  2012-01 · Subject: Pinitol; (1R,2R,4R,5R)-6-methoxycyclohexane-1,2,3,4,5-pentol; ZINC3978754; ZINC242463987; ononitol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01738763 Completed (results not assessed here)
  Effects of Different Doses of Pinitol on Carbohydrate Metabolism Parameters in Healthy Subjects
  Condition or outcome area: Healthy|Insulin Sensitivity
  2011-07 · Subject: Pinitol; (1R,2R,4R,5R)-6-methoxycyclohexane-1,2,3,4,5-pentol; ZINC3978754; ZINC242463987; ononitol · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01708915 Phase 3 Completed (results not assessed here)
  Nonivamide/Nicoboxil Ointment in Acute Low Back Pain
  Condition or outcome area: Acute Low Back Pain
  2012-10 · Subject: Nonivamide; nonyl vanillylamide; nonoyl vanillylamide; BRN 2144300; Nonivamida [INN-Spanish]; Spectrum_000311; Pelargonyl vanillylamide; 2444-46-4; Nonylic acid vanillylamide; Capsaicin synthetic · open the ingredient record · ClinicalTrials.gov
• Systematic review registration CRD42021230367 Registered protocol, no results here: Review Ongoing
  The efficacy of Shenghua Decoction supplementation after early medical abortion: a meta-analysis of randomized controlled trials
  Condition or outcome area: Medical abortion, which recommended by the World Health Organization (WHO) using a combination of mifepristone followed by misoprostol, is increasingly being used to end an early pregnancy with approximately 98% effective, and considered as a safe, noninvasive, affordable and acceptable alternative worldwide over traditional dilatation and curettage. Despite excellent effectiveness and safety, incomplete abortion and excessive and prolonged uterine bleeding are among the major limitations in suc
  2021-02-09 · Subject: Sheng Hua Tang; 生化汤; Sheng Hua Decoction · open the formula record
• Systematic review registration CRD42020184465 Registered protocol, no results here: Review Ongoing
  Effect of herbal medicine Shenghua decoction on uterine bleeding after early medical abortion: a protocol for a systematic review and meta-analysis
  Condition or outcome area: Unintended pregnancy is a problem that women encounter throughout their reproductive years. Medical termination of pregnancy has played a crucial role in providing access to safe, effective alternative worldwide by being noninvasive. However, the acceptability is not high as expected. Excessive and prolonged uterine bleeding is an important obstacle to get popularized. Herbal medicine Shenghua decoction is widely used throughout China and elsewhere in the world for the treating uterine bleeding
  2020-07-14 · Subject: Sheng Hua Tang; 生化汤; Sheng Hua Decoction · open the formula record
• Systematic review registration CRD42020209451 Registered protocol, no results here: Review Ongoing
  A meta-analysis of effectiveness and safety of non-vitamin K oral anticoagulant compared to vitamin K antagonists in patients with left ventricular thrombosis
  Condition or outcome area: Left ventricular (LV) thrombi are associated with LV dysfunction. They can occur as a complication of acute myocardial infarction but may arise in nonischemic cardiomyopathies as well. Despite decades of study of LV thrombi, data of which we are aware regarding their treatment, particularly in the prevention of embolic events, are scarce. Non-vitamin K oral anticoagulant (NOACs) are highly selective direct factor Xa with oral bioavailability and rapid onset of action. They have predictable pharm
  2020-10-16 · Subject: Vitamin k; Vitamin K; 12001-79-5; 81818-54-4; Kephton; 2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione; Vitamin K1(20); .alpha.-Phylloquinone; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione · open the ingredient record
• Systematic review registration CRD42020169620 Registered protocol, no results here: status not recorded
  Effects of resveratrol supplementation on vascular function: a systematic review and meta-analysis
  Condition or outcome area: Vascular function is regulated by many cell components, including vascular smooth muscle cells, endothelial cells, and adventitial tissues with infammatory cells, autonomic nervous system, and vasa vasorum. Changes in vascular function such as endothelial dysfunction and arterial stifness are key early features in the development of cardiovascular disease (CVD). Several noninvasive methods to assess vascular function have been developed, and two of them may be highlighted: fow-mediated dilation
  Subject: Trans-resveratrol; Resveratrol; resveratrol; 501-36-0; 3,4',5-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; 3,5,4'-Trihydroxystilbene; (E)-resveratrol; Resvida; 3,4',5-Stilbenetriol · open the ingredient record
• Systematic review registration CRD42022314774 Registered protocol, no results here: Review Ongoing
  Isosorbide Mononitrate Combined with Compound Danshen Dripping Pills in the Treatment of Coronary Heart Disease Angina Pectoris: A Systematic Review and Meta-analysis
  Condition or outcome area: 1.Coronary atherosclerotic heart disease refers to heart disease caused by myocardial ischemia, hypoxia or necrosis caused by coronary atherosclerosis that narrows, spasms or blocks the lumen of the coronary artery. According to the China Cardiovascular Health and Disease Report 2020:The prevalence of coronary heart disease in the population aged 15 and over is 12.3‰. The common clinical manifestations of coronary heart disease are angina pectoris (37.8%) and myocardial infarction (14.9%) .The m
  2022-04-07 · Subject: Isosorbide; 652-67-5; Isobide; Ismotic; Devicoran; Hydronol; Sorbid; (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol; (+)-D-Isosorbide; 1,4:3,6-Dianhydro-D-glucitol · open the ingredient record
• Systematic review registration CRD42018107227 Registered protocol, no results here: Review Ongoing
  Comparative efficacy and safety of dinoprostone, misoprostol and isosorbide mononitrate (IMN) for cervical ripening in outpatient settings: a systematic review and network meta-analysis
  Condition or outcome area: Try to find the best treatment for cervical ripening in outpatient setting.
  2018-08-28 · Subject: Isosorbide; 652-67-5; Isobide; Ismotic; Devicoran; Hydronol; Sorbid; (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol; (+)-D-Isosorbide; 1,4:3,6-Dianhydro-D-glucitol · open the ingredient record
• Systematic review registration CRD42016045587 Registered protocol, no results here: Review Ongoing
  Beta-blockers alone or in combination with isosorbide mononitrate for secondary prevention of bleeding from gastro-esophageal varices in adults with cirrhosis and gastro-oesophageal varices [Cochrane Protocol]
  Condition or outcome area: The Cochrane Hepato-Biliary Group
  2016-08-09 · Subject: Isosorbide; 652-67-5; Isobide; Ismotic; Devicoran; Hydronol; Sorbid; (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol; (+)-D-Isosorbide; 1,4:3,6-Dianhydro-D-glucitol · open the ingredient record
• Systematic review registration CRD42015026556 Registered protocol, no results here: Review Ongoing
  Beta-blockers alone or with isosorbide mononitrate for primary prevention in adults with cirrhosis and gastro-oesophageal varices [Cochrane Protocol]
  Condition or outcome area: The Cochrane Hepato-Biliary Group
  2015-09-24 · Subject: Isosorbide; 652-67-5; Isobide; Ismotic; Devicoran; Hydronol; Sorbid; (3R,3aR,6S,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol; (+)-D-Isosorbide; 1,4:3,6-Dianhydro-D-glucitol · open the ingredient record
• Systematic review registration CRD42022353413 Registered protocol, no results here: Review Ongoing
  The Hepatoprotective Potential of Mangiferin in Liver Diseases: a Meta Analysis
  2022-10-04 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record
• Systematic review registration CRD42021267839 Registered protocol, no results here: Review Ongoing
  A systematic review of cannabidiol utilization for treatment in neurodevelopmental disorders
  Condition or outcome area: Cannabidiol (CBD) is a nonintoxicating phyto-cannabinoid present in the Cannabis sativa plant (VanDolah et al., 2019). A mounting body of evidence indicates that CBD can treat cognitive, social, communication, and behavioural symptoms observed in neurodevelopmental disorders. The endocannabinoid system has been linked to phenotypic features observed in neurodevelopmental disorders, including autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD), and Tourette’s syndrome
  2021-08-13 · Subject: Cannabidiol; 13956-29-1; (-)-Cannabidiol; (-)-trans-Cannabidiol; Epidiolex; CBD; (-)-CBD; GWP42003-P; CARDIOLRX; Cannabidiol [USAN] · open the ingredient record
• Systematic review registration CRD42020151001 Registered protocol, no results here: Review Completed published
  Berberine for diarrhea: a systematic review and meta-analysis
  Condition or outcome area: Diarrhea is defined as the passage of three or more loose or liquid stools per day (or more frequent passage than is normal for the individual). Diarrhea is a common symptom of intestinal tract infections and noninfectious problems. It can be caused by a variety of bacterial, viral parasitic organisms, improper diet and allergy, etc. The etiological diagnosis of diarrhea is based on medical history, symptoms, and routine testing (especially stool testing). Continued diarrhea leads to loss of flu
  2020-02-21 · Subject: Berberime; Berberine; berberine; 2086-83-1; Umbellatine; Berberin; Berbericine; Majarine; Thalsine; Umbellatin · open the ingredient record
• Publication PMID 34025405 Research model: Animal Experiment
  BYHWD Alleviates Inflammatory Response by NIK-Mediated Repression of the Noncanonical NF-κB Pathway During ICH Recovery
  Condition or outcome area: stroke; cerebral edema; Intracerebral hemorrhage; chronic inflammation
  Front Pharmacol · 2021 · Subject: Bu Yang Hai Wu Tang; 补阳还五汤; Bu Yang Huan Wu Decoction · open the formula record · DOI 10.3389/fphar.2021.632407
• Publication PMID 36290645 Research model: Animal & Cell Experiment
  Maltol, a Natural Flavor Enhancer, Inhibits NLRP3 and Non-Canonical Inflammasome Activation
  Condition or outcome area: inflammatory diseases
  Antioxidants (Basel) · 2022 · Subject: Vetol; Maltol; MALTOL; 118-71-8; 3-Hydroxy-2-methyl-4-pyrone; 3-Hydroxy-2-methyl-4H-pyran-4-one; Larixinic acid; Palatone; Talmon; Larixic acid · open the ingredient record · DOI 10.3390/antiox11101923
• Publication PMID 35708264 Research model: Cell Experiment
  Ursolic acid inhibits the activation of smoothened-independent non-canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade
  Condition or outcome area: multiple malignancies; colorectal cancer; cancers
  Phytother Res · 2022 · Subject: Ursolic acid; Ursolic Acid; 77-52-1; Prunol; Malol; Urson; 3beta-Hydroxyurs-12-en-28-oic acid; Micromerol; (3beta)-3-Hydroxyurs-12-en-28-oic acid; (+)-Ursolic acid · open the ingredient record · DOI 10.1002/ptr.7523
• Publication PMID 34417574 Research model: Animal Experiment
  Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages
  Condition or outcome area: attenuated silicosis; inflammation; silicosis; Silicosis; silicosis-associated inflammation; fibrosis
  Acta Pharmacol Sin · 2021 · Subject: Tetrandrine; 518-34-3; D-Tetrandrine; (+)-Tetrandrine; Tetrandrin; Fanchinine; Sinomenine A; (S,S)-Tetrandrine; hanjisong; DL-Tetrandine · open the ingredient record · DOI 10.1038/s41401-021-00693-6
• Publication PMID 31678492 Research model: Cell Experiment
  Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells
  Condition or outcome area: ferroptosis; lung cancer; programmed necrosis; pyroptosis; necroptosis
  Biochem Pharmacol · 2020 · Subject: Tanshinol a; Tanshinol A; 6-(Hydroxymethyl)-1-methylphenanthro[1,2-b]furan-10,11-dione; 189290-28-6 · open the ingredient record · DOI 10.1016/j.bcp.2019.113684
• Publication PMID 36559338 Research model: Cell Experiment
  Effects of Mangiferin on LPS-Induced Inflammation and SARS-CoV-2 Viral Adsorption in Human Lung Cells
  Condition or outcome area: mitochondrial dysfunction; COVID-19 infection
  Pharmaceutics · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3390/pharmaceutics14122845
• Publication PMID 36499655 Research model: Animal Experiment
  Mangiferin Ameliorates Obesity-Associated Inflammation and Autophagy in High-Fat-Diet-Fed Mice: In Silico and In Vivo Approaches
  Condition or outcome area: obesity; metabolic diseases; metabolic syndrome; tumor; high-fat-diet; obese; metabolic disorders
  Int J Mol Sci · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3390/ijms232315329
• Publication PMID 36408274 Research model: Animal Experiment
  Mangiferin promotes osteogenic differentiation and alleviates osteoporosis in the ovariectomized mouse via the AXL/ERK5 pathway
  Condition or outcome area: osteoporosis
  Front Pharmacol · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3389/fphar.2022.1028932
• Publication PMID 36332683 Research model: Cell Experiment
  Mangiferin alleviates hyperglycemia-induced endothelial impairment via Nrf2 signaling pathway
  Eur J Pharmacol · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.ejphar.2022.175359
• Publication PMID 36077522 Research model: Cell Experiment
  Anti-Inflammation and Anti-Pyroptosis Activities of Mangiferin via Suppressing NF-κB/NLRP3/GSDMD Signaling Cascades
  Condition or outcome area: pyroptosis
  Int J Mol Sci · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3390/ijms231710124
• Publication PMID 35778992 Research model: Cell Experiment
  Mangiferin prevents hepatocyte epithelial-mesenchymal transition in liver fibrosis via targeting HSP27-mediated JAK2/STAT3 and TGF-β1/Smad pathway
  Condition or outcome area: fibrosis; liver injury; liver fibrosis; hepatic fibrosis; liver cirrhosis
  Phytother Res · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1002/ptr.7549
• Publication PMID 35752080 Research model: Animal Experiment
  Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of Parkinson's disease
  Condition or outcome area: motor deficiency; neurodegenerative disease; Parkinson's disease; mitochondrial dysfunction
  Phytomedicine · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.phymed.2022.154281
• Publication PMID 35721155 Research model: Cell Experiment
  Mangiferin Alleviates Postpartum Depression-Like Behaviors by Inhibiting MAPK Signaling in Microglia
  Condition or outcome area: mental health disorder; Postpartum depression
  Front Pharmacol · 2022 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3389/fphar.2022.840567
• Publication PMID 33923922 Research model: Cell Experiment
  Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway
  Int J Mol Sci · 2021 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3390/ijms22084259
• Publication PMID 33523605 Research model: Animal & Cell Experiment
  Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1/FoxO3a pathway
  Condition or outcome area: Myocardial infarction; heart failure; cardiovascular diseases
  J Cell Mol Med · 2021 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1111/jcmm.16329
• Publication PMID 32969440 Research model: Animal & Cell Experiment
  Mangiferin protects against alcoholic liver injury via suppression of inflammation-induced adipose hyperlipolysis
  Condition or outcome area: alcoholic liver disease; alcoholic liver injury; ethanol-induced liver injury; Adipose dysfunction; liver injury
  Food Funct · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1039/d0fo01436b
• Publication PMID 32417366 Research model: Cell Experiment
  Mangiferin induces the expression of a thermogenic signature via AMPK signaling during brown-adipocyte differentiation
  Condition or outcome area: obesity
  Food Chem Toxicol · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.fct.2020.111415
• Publication PMID 32408566 Research model: Animal Experiment
  Mangiferin Alleviates Ovalbumin-Induced Allergic Rhinitis via Nrf2/HO-1/NF-κB Signaling Pathways
  Condition or outcome area: nasal mucosa inflammation; nasal mucosal inflammation; allergic rhinitis
  Int J Mol Sci · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3390/ijms21103415
• Publication PMID 32353588 Research model: Animal Experiment
  Mangiferin activates Nrf2 to attenuate cardiac fibrosis via redistributing glutaminolysis-derived glutamate
  Condition or outcome area: metabolic disorders; Cardiac injury; impaired heart function; transverse aortic constriction; myocardial systolic and diastolic dysfunction; cardiac fibrosis; fibrosis
  Pharmacol Res · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.phrs.2020.104845
• Publication PMID 32289346 Research model: Cell Experiment
  PINK1-PRKN mitophagy suppression by mangiferin promotes a brown-fat-phenotype via PKA-p38 MAPK signalling in murine C3H10T1/2 mesenchymal stem cells
  Condition or outcome area: obesity; diabetes; cancer
  Metabolism · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.metabol.2020.154228
• Publication PMID 32158448 Research model: Animal & Cell Experiment
  Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells
  Condition or outcome area: hepatic encephalopathy; hepatic failure; Acute liver injury; acute liver injury; inflammatory response syndrome; multiorgan failure
  Front Immunol · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3389/fimmu.2020.00285
• Publication PMID 32119962 Research model: Animal Experiment
  Mangiferin exert cardioprotective and anti-apoptotic effects in heart failure induced rats
  Condition or outcome area: heart failure
  Life Sci · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.1016/j.lfs.2020.117476
• Publication PMID 32116724 Research model: Animal Experiment
  Mangiferin Ameliorates Hyperuricemic Nephropathy Which Is Associated With Downregulation of AQP2 and Increased Urinary Uric Acid Excretion
  Condition or outcome area: hyperuricemic nephropathy; Hyperuricemia; inflammation; renal inflammation; endothelial dysfunction; renal dysfunction; fibrosis; kidney injury
  Front Pharmacol · 2020 · Subject: Mangiferin; 4773-96-0; Chinonin; Alpizarin; Hedysarid; Aphloiol; Chinomin; Alpizarine; UNII-1M84LD0UMD; 1M84LD0UMD · open the ingredient record · DOI 10.3389/fphar.2020.00049
• Publication PMID 30412793 Research model: Cell Experiment
  Ferutinin directs dental pulp-derived stem cells towards the osteogenic lineage by epigenetically regulating canonical Wnt signaling
  Condition or outcome area: bone deterioration; systemic disease; Osteoporosis; osteoporosis
  Biochim Biophys Acta Mol Basis Dis · 2020 · Subject: Ferutinin; Ferutinine; 41743-44-6; Jaeschkeanadiol p-hydroxybenzoate; 4-Oxy-6-(4-oxybezoyloxy)dauc-8,9-en; [(3R,3aS,4S,8aR)-3-hydroxy-6,8a-dimethyl-3-propan-2-yl-1,2,3a,4,5,8-hexahydroazulen-4-yl] 4-hydroxybenzoate; Tefestrol; Benzoic acid, 4-hydroxy-, (3R,3aS,4S,8aR)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-4-azulenyl ester; Benzoic acid, 4-hydroxy-, 1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-4-azulenyl ester, (3R-(3alpha,3abeta,4beta,8aal · open the ingredient record · DOI 10.1016/j.bbadis.2018.10.032
• Publication PMID 35766262 Research model: Animal Experiment
  Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2-Mediated Suppression of NLRP3 Inflammasome Activation
  Condition or outcome area: heart failure; Dilated cardiomyopathy; fibrosis; dilated cardiomyopathy; nonischemic heart failure
  J Am Heart Assoc · 2022 · Subject: Colchicine; 64-86-8; Colchisol; Colchicinum; Colchicin; Colchicina; Colchineos; Condylon; Colcin; Colsaloid · open the ingredient record · DOI 10.1161/JAHA.122.025266
• Publication PMID 35912256 Research model: Cell Experiment
  Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway
  Condition or outcome area: laryngeal cancer; laryngeal cancer Hep-2; head and neck tumor; Laryngeal cancer
  Front Oncol · 2022 · Subject: Ononin; 486-62-4; Formononetin glucoside; Formononetin 7-O-glucoside; formononetin-7-O-glucoside; Ononoside; 4'-Methoxyisoflavone-7-O-beta-D-glucopyranoside; Formononetin-7-O-beta-D-glucopyranoside; CHEBI:7775; UNII-Z0Z637970U · open the ingredient record · DOI 10.3389/fonc.2022.939646
• Publication PMID 33734250 Research model: Cell Experiment
  Immunomodulatory effect of Noni fruit and its isolates: insights into cell-mediated immune response and inhibition of LPS-induced THP-1 macrophage inflammation
  Condition or outcome area: paw edema
  Food Funct · 2021 · Subject: Hai Bin Mu Ba Ji; 海滨木巴戟; Indianmulberry; Morinda Citrifolia · open the herb record · DOI 10.1039/d0fo03402a
• Publication PMID 33182564 Research model: Animal Experiment
  Therapeutic Effects of Morinda citrifolia Linn. (Noni) Aqueous Fruit Extract on the Glucose and Lipid Metabolism in High-Fat/High-Fructose-Fed Swiss Mice
  Nutrients · 2020 · Subject: Hai Bin Mu Ba Ji; 海滨木巴戟; Indianmulberry; Morinda Citrifolia · open the herb record · DOI 10.3390/nu12113439
• Publication PMID 32298014 Research model: Animal Experiment
  Morinda citrifolia (Noni) fruit juice promotes vascular endothelium function in hypertension via glucagon-like peptide-1 receptor-CaMKKβ-AMPK-eNOS pathway
  Condition or outcome area: hypertension
  Phytother Res · 2020 · Subject: Hai Bin Mu Ba Ji; 海滨木巴戟; Indianmulberry; Morinda Citrifolia · open the herb record · DOI 10.1002/ptr.6685
• Publication PMID 31963703 Research model: Animal Experiment
  Fermented Morinda citrifolia (Noni) Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice through Modulating Immune Balance and Skin Barrier Function
  Condition or outcome area: AD lesions; inflammatory diseases; AD-like skin lesions; atopic dermatitis; dermatitis
  Nutrients · 2020 · Subject: Hai Bin Mu Ba Ji; 海滨木巴戟; Indianmulberry; Morinda Citrifolia · open the herb record · DOI 10.3390/nu12010249